Dr. Jay Suriar is a distinguished Resident Consultant Hematologist at Gleneagles Hospital Kuala Lumpur, specializing in the intricate investigation and treatment of benign and malignant blood diseases, including blood cancers and clotting/bleeding disorders. He is a co-investigator in Phase 3 clinical trials, a contributor to Ministry of Health Clinical Practice Guidelines, and a former Council Member of the Malaysian Society of Haematology. Dr. Suriar's patient care philosophy emphasizes proactive patient blood management to minimize transfusions and prevent clotting complications, offering cutting-edge, individualized care.